Background and Purpose—The purpose of these guidelines is to provide an up-to-date
comprehensive set of recommendations in a single document for clinicians caring for adult …

Stroke is the second highest cause of death globally and a leading cause of disability, with
an increasing incidence in developing countries. Ischaemic stroke caused by arterial …

Background Under current guidelines, intravenous thrombolysis is used to treat acute stroke
only if it can be ascertained that the time since the onset of symptoms was less than 4.5 …

Background Tenecteplase is a modified tissue plasminogen activator with pharmacological
and practical advantages over alteplase—which is currently the only approved thrombolytic …

Two previous pan-European consensus meetings, the 1995 and 2006 Helsingborg
meetings, were convened to review the scientific evidence and the state of current services …

Background Due to the time-sensitive effect of endovascular treatment, rapid prehospital
identification of large-vessel occlusion in individuals with suspected stroke is essential to …

Background Aspirin and unfractionated heparin are often used during endovascular stroke
treatment to improve reperfusion and outcomes. However, the effects and risks of anti …

Purpose—Symptomatic intracranial hemorrhage (sICH) is the most feared complication of
intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on …

Purpose—The aim of this guideline is to provide a focused update of the current
recommendations for the endovascular treatment of acute ischemic stroke. Where there is …

Purpose—The aim of this guideline is to provide a focused update of the current
recommendations for the endovascular treatment of acute ischemic stroke. When there is …